FSGEX | RLITX | FSGEX / RLITX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 10 years | - |
Gain YTD | 6.570 | 0.668 | 984% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 48.2B | 3.32B | 1,454% |
Annual Yield % from dividends | 2.77 | 1.38 | 201% |
Returns for 1 year | 13.84 | 8.67 | 160% |
Returns for 3 years | 1.49 | -8.92 | -17% |
Returns for 5 years | 26.49 | 14.45 | 183% |
Returns for 10 years | 48.32 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BFTIX | 59.94 | 0.32 | +0.54% |
Baron Fifth Avenue Growth Instl | |||
LVFLX | 14.02 | N/A | N/A |
Lord Abbett Focused Large Cap Value R6 | |||
LBRIX | 32.62 | -0.03 | -0.09% |
ClearBridge Dividend Strategy FI | |||
FAVCX | 24.73 | -0.05 | -0.20% |
Fidelity Advisor Equity Value C | |||
FBTCX | 25.11 | -0.37 | -1.45% |
Fidelity Advisor Biotechnology C |